Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Other Non Operating Income (2016 - 2025)

CorMedix has reported Other Non Operating Income over the past 12 years, most recently at $75195.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $75195.0 for Q4 2025, up 123.95% from a year ago — trailing twelve months through Dec 2025 was -$51999.0 (down 134.98% YoY), and the annual figure for FY2025 was -$52000.0, down 127.96%.
  • Other Non Operating Income reached $75195.0 in Q4 2025 per CRMD's latest filing, up from -$72727.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $500000.0 in Q2 2024 and bottomed at -$314000.0 in Q4 2024.
  • Median Other Non Operating Income over the past 5 years was -$5433.5 (2021), compared with a mean of $9752.6.
  • Peak annual rise in Other Non Operating Income hit 3840.28% in 2024, while the deepest fall reached 25670.03% in 2024.
  • Over 5 years, Other Non Operating Income stood at -$11066.0 in 2021, then soared by 150.13% to $5547.0 in 2022, then tumbled by 77.86% to $1228.0 in 2023, then crashed by 25670.03% to -$314000.0 in 2024, then soared by 123.95% to $75195.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CRMD at $75195.0 in Q4 2025, -$72727.0 in Q3 2025, and -$16295.0 in Q2 2025.